881841-32-3 Usage
Description
6-Fluoroimidazo[1,2-a]pyridine-2-carbaldehyde is a heterocyclic aromatic aldehyde with the molecular formula C8H5FN2O. It features a fluorine atom and a pyridine ring, making it a valuable chemical compound in various fields.
Uses
Used in Pharmaceutical and Agrochemical Industries:
6-Fluoroimidazo[1,2-a]pyridine-2-carbaldehyde serves as a building block in the synthesis of pharmaceuticals and agrochemicals. Its unique structure and potential biological activities make it a promising candidate for the development of new drugs and agrochemical products.
Used in Medicinal Chemistry and Drug Discovery:
Due to its potential biological activities, 6-fluoroiMidazo[1,2-a]pyridine-2-carbaldehyde is utilized in medicinal chemistry and drug discovery. Researchers can explore its properties to design and develop novel therapeutic agents with improved efficacy and selectivity.
Used as a Reagent in Organic Synthesis:
6-Fluoroimidazo[1,2-a]pyridine-2-carbaldehyde can also be used as a reagent in organic synthesis. It enables the introduction of the 6-fluoroimidazo[1,2-a]pyridine-2-carbaldehyde moiety into various organic molecules, expanding the scope of chemical reactions and products that can be achieved.
Overall, 6-fluoroimidazo[1,2-a]pyridine-2-carbaldehyde is an important chemical intermediate with diverse industrial and research applications, making it a valuable asset in the fields of chemistry and biology.
Check Digit Verification of cas no
The CAS Registry Mumber 881841-32-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,1,8,4 and 1 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 881841-32:
(8*8)+(7*8)+(6*1)+(5*8)+(4*4)+(3*1)+(2*3)+(1*2)=193
193 % 10 = 3
So 881841-32-3 is a valid CAS Registry Number.
881841-32-3Relevant articles and documents
CHEMICAL COMPOUNDS 635 : PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS
-
Page/Page column 38, (2008/12/07)
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE 4 mediated disease state.
